Financial News
Stories about Aimmune Therap
Aimmune Therapeutics Larger Than S&P 500 Component Under Armour
September 25, 2020
Tags
Stocks
From Market News Video
Why Aimmune Therapeutics Stock Jumped by 159% in August
September 08, 2020
From Motley Fool
2 Mid-Cap Healthcare Stocks to Buy Now
September 05, 2020
From Motley Fool
Benzinga's Top Upgrades, Downgrades For September 1, 2020
September 01, 2020
From Benzinga
Surge in megadeals points to M&A recovery as tech sector dominates
September 01, 2020
From MarketWatch
10 Biggest Price Target Changes For Tuesday
September 01, 2020
From Benzinga
60 Biggest Movers From Yesterday
September 01, 2020
From Benzinga
Stock Markets Celebrate a Strong August; Nestle's Hungry for Aimmune as Utz Feeds IPO Investors
August 31, 2020
From Motley Fool
Mid-Afternoon Market Update: Nasdaq Rises Over 100 Points; Regis Shares Drop After Q4 Results
August 31, 2020
From Benzinga
Aimmune Therapeutics soars 172% after Nestle agrees to acquire the peanut allergy treatment company for $2.6 billion (AIMT)
August 31, 2020
From Business Insider
European stocks fall on the last day of August trading
August 31, 2020
From MarketWatch
50 Stocks Moving In Monday's Mid-Day Session
August 31, 2020
From Benzinga
50 Stocks Moving In Monday's Mid-Day Session
August 31, 2020
From Benzinga
Mid-Day Market Update: Akcea Therapeutics Jumps Following Acquisition News; Acasti Pharma Shares Plummet
August 31, 2020
From Benzinga
Mid-Morning Market Update: Markets Mostly Lower; Nestlé To Acquire Aimmune Therapeutics
August 31, 2020
From Benzinga
Nestle Acquires Aimmune For $34.50 Per Share In Cash Or $2.6B
August 31, 2020
From Blogs - TalkMarkets
ROCE Insights For Aimmune Therapeutics
August 31, 2020
From Benzinga
Why Aimmune Therapeutics Stock Is Soaring Today
August 31, 2020
From Motley Fool
An ‘extreme’ August on the stock market might be telling us something about the November election
August 31, 2020
From MarketWatch
38 Stocks Moving in Monday's Pre-Market Session
August 31, 2020
From Benzinga
From Benzinga
Aimmune Shares Surge 170% As Nestle Set To Acquire Company At $2.6B Enterprise Value
August 31, 2020
From Benzinga
Could This Small-Cap Biotech Stock Make You Rich?
August 11, 2020
From Motley Fool
Is Aimmune Therapeutics a Buy?
August 06, 2020
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
